Repligen (RGEN) Tops Q3 EPS by 9c. Updates Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $126.37 -0.16%
EPS Growth %: +21.6%
Financial Fact:
Income tax provision: 1.06M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +21.6%
Financial Fact:
Income tax provision: 1.06M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $200.7 million versus the consensus estimate of $192.68 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.15-$3.20, versus the consensus of $3.20. Repligen sees FY2022 revenue of $795-805 million, versus the consensus of $804 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- After-Hours Stock Movers: FDX, CBRS, NKE
- CVG to join Russell 2000 and Russell 3000 indexes June 26
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
